Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fedro A. Peccatori,Hatem A. Azim,Roberto Orecchia,Harald J. Hoekstra,Nicholas Pavlidis,V. Kesic,George Pentheroudakis +6 more
Reads0
Chats0
TLDR
The aim of this work is to provide a systematic review and meta-analysis of the literature on canine coronavirus infection and its role in infertility and procreation that has been reported on in previous studies and is concerned with the well-being of newborns.About:
This article is published in Annals of Oncology.The article was published on 2013-10-01 and is currently open access. It has received 598 citations till now.read more
Citations
More filters
Journal ArticleDOI
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
Mehran Alavi,Mehrdad Hamidi +1 more
TL;DR: An overview of the current position of the liposome-based drug delivery systems in targeted anticancer chemotherapy is presented, presented with high functionality in chemotherapeutic targeting of breast and prostate cancer.
Journal ArticleDOI
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
Matteo Lambertini,Marcello Ceppi,Francesca Poggio,Fedro A. Peccatori,Hatem A. Azim,Donatella Ugolini,Paolo Pronzato,Sibylle Loibl,Halle C. F. Moore,Ann H. Partridge,Paolo Bruzzi,L. Del Mastro +11 more
TL;DR: Temporary ovarian suppression with LHRHa in young breast cancer patients is associated with a reduced risk of chemotherapy-induced POF and seems to increase the pregnancy rate, without an apparent negative consequence on prognosis.
Journal ArticleDOI
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial
Matteo Lambertini,Luca Boni,Andrea Michelotti,Teresa Gamucci,Tiziana Scotto,Stefania Gori,Monica Giordano,Ornella Garrone,Alessia Levaggi,Francesca Poggio,S. Giraudi,Claudia Bighin,C. Vecchio,Mario Roberto Sertoli,Paolo Pronzato,Lucia Del Mastro +15 more
TL;DR: Among premenopausal women with either hormones receptor-positive or hormone receptor-negative breast cancer, concurrent administration of triptorelin and chemotherapy, compared with chemotherapy alone, was associated with higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate.
Journal ArticleDOI
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Shani Paluch-Shimon,Fatima Cardoso,Ann H. Partridge,O.A. Abulkhair,Hatem A. Azim,G. Bianchi-Micheli,Maria João Cardoso,Maria João Cardoso,Giuseppe Curigliano,Giuseppe Curigliano,Karen A. Gelmon,Nadia Harbeck,J. Merschdorf,Philip Poortmans,Giancarlo Pruneri,Elżbieta Senkus,Tanja Spanic,Vered Stearns,Yvonne Wengström,Fedro A. Peccatori,Olivia Pagani +20 more
TL;DR: This manuscript summarizes the ESO-ESMO international consensus recommendations for the management of breast cancer in young women, which are also endorsed by the European Society of Breast Specialists (EUSOMA).
Journal ArticleDOI
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
Lucia Del Mastro,Marcello Ceppi,Francesca Poggio,Claudia Bighin,Fedro A. Peccatori,Isabelle Demeestere,Alessia Levaggi,S. Giraudi,Matteo Lambertini,Alessia D'Alonzo,Giuseppe Canavese,Paolo Pronzato,Paolo Bruzzi +12 more
TL;DR: A systematic review and meta-analysis of randomized trials evaluating the efficacy of GnRHa, given before and during chemotherapy, in the prevention of POF in premenopausal cancer patients shows that the temporary ovarian suppression induced by GnR Ha significantly reduces the risk of chemotherapy-induced POFIn young cancer patients.
References
More filters
Journal ArticleDOI
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Joseph A. Sparano,Joseph A. Sparano,Molin Wang,Silvana Martino,Vicky Jones,Edith A. Perez,Tom Saphner,Antonio C. Wolff,George W. Sledge,William C. Wood,Nancy E. Davidson +10 more
TL;DR: In this paper, the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer was compared.
Journal ArticleDOI
Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation
TL;DR: The combination of low-dose FSH with tamoxifen (TamFSH-IVF) or letrozole (Letrozoles- IVF) results in higher embryo yield compared with Tam-IVf, and the letroZole protocol may be preferred because it results in lower peak E2 levels.
Journal Article
Delayed childbearing: more women are having their first child later in life
T J Matthews,Brady E Hamilton +1 more
TL;DR: The age of the mother plays a strong role in a wide range of birth outcomes (e.g., birthweight, multiple births, and birth defects), so it is critical to track the average age at which women have their first birth.
Journal ArticleDOI
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.
TL;DR: The diagnosis of most cancer types during pregnancy or lactation does not increase the risk of cause-specific death, and the "healthy mother effect" for women with a postcancer pregnancy is confirmed.
Journal ArticleDOI
Safety of Fertility Preservation by Ovarian Stimulation With Letrozole and Gonadotropins in Patients With Breast Cancer: A Prospective Controlled Study
TL;DR: Ovarian stimulation with gonadotropins and letrozole for the purpose of fertility preservation is unlikely to cause substantially increased recurrence risk, and longer-term follow-up is needed to confirm these findings.
Related Papers (5)
Cancer and fertility preservation: international recommendations from an expert meeting
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Halle C. F. Moore,Joseph M. Unger,Kelly-Anne Phillips,Frances M. Boyle,Frances M. Boyle,Erika Hitre,David L. Porter,Prudence A. Francis,Lori J. Goldstein,Henry L. Gomez,Carlos S. Vallejos,Ann H. Partridge,Shaker R. Dakhil,Agustin A. Garcia,Julie R. Gralow,Janine M. Lombard,John F. Forbes,Silvana Martino,William E. Barlow,Carol J. Fabian,Lori M. Minasian,Frank L. Meyskens,Richard D. Gelber,Gabriel N. Hortobagyi,Kathy S. Albain +24 more